(Q33984087)

30 July 2017

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies (English)

1 reference

30 July 2017

Signe Borgquist

9

0 references

author name string

Quinci Romero

1

1 reference

30 July 2017

Pär-Ola Bendahl

2

1 reference

30 July 2017

Marie Klintman

3

1 reference

30 July 2017

Niklas Loman

4

1 reference

30 July 2017

Christian Ingvar

5

1 reference

30 July 2017

Lisa Rydén

6

1 reference

30 July 2017

Carsten Rose

7

1 reference

30 July 2017

Dorthe Grabau

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

7 August 2011

1 reference

30 July 2017

1 reference

30 July 2017

11

1 reference

30 July 2017

341

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-341

30 July 2017

0 references

cites work

Neoadjuvant therapy for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Neoadjuvant endocrine treatment in primary breast cancer - review of literature.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Neoadjuvant chemotherapy for locally advanced breast cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Evaluation of biological agents targeted at early-stage disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Research issues affecting preoperative systemic therapy for operable breast cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Measuring proliferation in breast cancer: practicalities and applications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Ultrasound-guided vacuum-assisted core breast biopsy: experience with 406 cases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Radiological features and pathological-biological correlations in 348 women with breast cancer under 35 years old.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Proliferation marker Ki-67 in early breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Designing the future shape of breast cancer diagnosis, prognosis and treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

The biology of neoadjuvant chemotherapy for breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

Cell cycle alterations and their relationship to proliferation in apocrine adenosis of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

Histopathological criteria and selection algorithms for BRCA1 genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

Assessment of microvessel density in core needle biopsy specimen in breast cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Molecular Grading of Ductal Carcinoma In situ of the Breast

29 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-341

Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163632

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

10 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21819622

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21819622

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21819622

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-11-341

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference